Development of CpG oligodeoxynucleotide TLR9 agonists in anti-cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of CpG oligodeoxynucleotide TLR9 agonists in anti-cancer therapy

Published:2021-04-15 Issue:8 Volume:21 Page:841-851
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Jin Yizhen¹,Zhuang Yuxin¹,Dong Xiaowu¹²,Liu Mei³^ORCID

Affiliation:

1. Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, P.R. China

2. Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou, P.R. China

3. Department of Neurology, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, P.R. China

Funder

the Natural Science Foundation of Zhejiang Province

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2021.1915136

Reference87 articles.

1. The role of Toll-like receptors in chronic inflammation

2. Dual character of Toll-like receptor signaling: Pro-tumorigenic effects and anti-tumor functions

3. A Toll-like receptor recognizes bacterial DNA

4. Toll-like receptor regulation of effector T lymphocyte function

5. TLR9 signals after translocating from the ER to CpG DNA in the lysosome

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomedicine-induced programmed cell death in cancer therapy: mechanisms and perspectives;Cell Death Discovery;2024-08-29

2. Recent developments in two-dimensional molybdenum disulfide-based multimodal cancer theranostics;Journal of Nanobiotechnology;2024-08-28

3. Resolution of chronic inflammation and cancer;Periodontology 2000;2024-08-23

4. DNA Dissipative System for Controlled Release of Immunostimulatory CpG Oligodeoxynucleotides;Advanced NanoBiomed Research;2024-07-30

5. Trained immunity inducers in cancer immunotherapy;Frontiers in Immunology;2024-07-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3